(Q35183771)

7 August 2017

1 reference

title

Budesonide/formoterol for the treatment of asthma (English)

1 reference

7 August 2017

1 reference

budesonide/formoterol

1 reference

Roland Buhl

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Pharmacotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

1393-1406

1 reference

Improving patient compliance with asthma therapy

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Interactions between corticosteroids and beta agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1393

Strengthening asthma education to enhance disease control

21 January 2018

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1378/CHEST.121.5.1661

Identifiers

DOI

10.1517/14656566.4.8.1393

1 reference

7 August 2017

1 reference